Lieven Huang – Startup Investor Profile

Lieven Huang is the Investment Manager Life Science & Medtech at the Brabant Development Agency (BOM). With a background in Bioengineering Sciences, Lieven is passionate about supporting early-stage companies to develop new treatments. His investment focus includes a broad portfolio ranging from discovery to clinical stage companies in the Life Science and Medtech sectors. Lieven’s previous investments and check sizes are not specified. Geographically, Lieven’s preference is not explicitly mentioned. His partnership and collaboration styles are not detailed. Lieven Huang excels in guiding creative problem-solving and ensuring successful outcomes.

Location: Netherlands

Country: Netherlands

Investment Regions: EU

Investment Stages: pre-seed, seed

Website: https://www.bom.nl/

AI Reasoning: BOM invested in InnoSIGN with an article stating the investment occurred in early 2022 and Lieven Huang is quoted. The startup invested: InnoSIGN. From early 2022 to the reference date is more than 12 months, but there is likely more recent activity: however only found investment dated early 2022. Since that is more than 12 months ago, classification should be low-active. But conflicting: The returned tag must be single. Given evidence only of early 2022 investment, time since last known investment is over 12 months -> low-active.

Low Activity – Only known angel investments more than 12 months ago.

Active – Known angel investments between the last 12 and 6 months.

Very Active – Known angel investments in the last 6 months.